Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force
- Ann G. Zauber, PhD;
- Iris Lansdorp-Vogelaar, MS;
- Amy B. Knudsen, PhD;
- Janneke Wilschut, MS;
- Marjolein van Ballegooijen, MD, PhD; and
- Karen M. Kuntz, ScD
- From Memorial Sloan-Kettering Cancer Center, New York, New York; Erasmus Medical Center, Rotterdam, the Netherlands; Massachusetts General Hospital, Boston, Massachusetts; and University of Minnesota, Minneapolis, Minnesota
-
Figure 2. Colonoscopies and life-years gained (compared with no screening) for a cohort of 1000 forty-year-olds for 18 colonoscopy screening strategies that vary by start age, stop age, and screening interval.
The numbers represent the following: age to beginage to stop screening, interval. MISCAN= Microsimulation Screening Analysis; SimCRC= Simulation Model of Colorectal Cancer.
-
Figure 3. Colonoscopies and life-years gained, by adherence level for the recommendable set of screening strategies.
SENSA= Hemoccult SENSA; FIT= fecal immunochemical testing; FSIG= flexible sigmoidoscopy; MISCAN= Microsimulation Analysis Model; SimCRC= Simulation Model of Colorectal Cancer. *The numbers represent the following: age to beginage to stop screening, interval.
RSS Feeds














